Experience
Scientific workspaces, scenario-guided workflows, and accessible data views.
Initializing
Initializing
Technology / Product architecture
Isolated module logic. Shared project context. Inspectable state transitions. An architecture for research that learns from its own evidence.
The intelligence stack
Scientific workspaces, scenario-guided workflows, and accessible data views.
Recursive task decomposition, specialist collaboration, and evidence-linked review.
Multi-objective drug design, genomic hypotheses, molecular exploration, and simulation.
Artifacts, annotations, and research lineage retained for reuse.
Project-scoped permissions and append-only, hash-linked audit requirements.
Modular services, asynchronous scientific workloads, and deployment-specific security controls.
Architecture summarized from the v2 PRD. Product requirements do not establish production availability or independent security assurance.
Illustrative platform visualization — not experimental validation data. Synthetic demonstration; subject to expert review.
Forward-looking experience
The Scientific Digital Twin is a conceptual extension—not a released capability or a validated biological model.
Scientific intelligence map
A map of scientific ambition—not a claim of validated capability in every domain. External quantum hardware and cross-domain expansion remain planned.
A Pareto frontier contains alternatives for which improving one objective requires accepting a trade-off elsewhere. It does not mean a candidate is safe, effective, or ready for development. FantomX emphasizes diverse reviewable alternatives rather than a universally best molecule.
Explore the related workflow →Site and product guidance only. No medical diagnosis, therapeutic recommendation, or live scientific inference.
FantomX.
From question to delivered science
Recursive agents. Multi-objective discovery.
Transparent evidence. Reusable scientific knowledge.